![Pills and a magnifying glass](https://www.ema.europa.eu/sites/default/files/styles/ema_carousel/public/2024-06/D10_WEB_PRAC%20highlights_homepage_slider.png?itok=QUk2-k9A)
New recommendation to minimise risk of aspiration with GLP-1 medicines during anaesthesia
![Person tacking medicine from a shelf](https://www.ema.europa.eu/sites/default/files/styles/ema_carousel/public/2024-06/2024-06_GLP1%20recommendations-3-_WEB_homepage-banner.png?itok=A_0z_r-H)
New recommendations to ensure these medicines reach those who need them most
![Revised transparency rules for Clinical Trials Information System (CTIS) have become applicable](https://www.ema.europa.eu/sites/default/files/styles/ema_carousel/public/2024-06/2024-06_CTIS%20transparency%20rules_WEB_homepage-banner.png?itok=FOCrNJBT)
Revised transparency rules for Clinical Trials Information System (CTIS) have become applicable
![Image of Ulla Wändel Liminga](https://www.ema.europa.eu/sites/default/files/styles/ema_carousel/public/2024-07/2024-07_PRAC%20chair_WEB_slider.png?itok=nA7BbtMM)
Ulla Wändel Liminga begins her mandate in September 2024, replacing Sabine Straus
![Image of annual report cover showing on laptop, leaflet, ipad, phone](https://www.ema.europa.eu/sites/default/files/styles/ema_carousel/public/2024-05/2024-05_Annual-report-2023-2-_WEB_slider.png?itok=7d5CVHjq)
How we contributed to public and animal health in the European Union
Find medicine
What's new
FAQs
Latest news
PRAC elects new chair
Opinion follows review of additional data and advice from group of experts.
Ulla Wändel Liminga will begin her three-year mandate in September 2024
New appointments in the Legal Department and the Regulatory Science and Innovation Task Force
![medicine pills and tablets](https://www.ema.europa.eu/sites/default/files/2023-11/Web%20image_CHMP_standard_square.png)
10 new medicines recommended for approval; another 11 medicines recommended for extension of their therapeutic indications
Benefits of Ocaliva no longer considered to outweigh its risks